Added to YB: 2025-11-03
Pitch date: 2025-10-31
KVUE [bullish]
Kenvue Inc.
+17.51%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America.
Market Cap
$36.1B
Pitch Price
$16.28
Price Target
N/A
Dividend
4.47%
EV/EBITDA
12.35
P/E
22.12
EV/Sales
2.83
Sector
Personal Care Products
Category
dividend
Show full summary:
Kenvue: Adding To Aggressive Portfolio Via Short Put Sale
KVUE (sold puts): Sold 2 naked Dec 19 $14 puts at $1.18; yields 8.4% return over 49 days or $12.82 entry (6.5% div yield). Stock -4pts on Tylenol/autism legal fears, now 13x fwd EPS. Tylenol just 10% of sales; -$20B mkt cap exceeds likely settlement. A-rated, div covered, weak scientific evidence.
Read full article (2 min)